Does QUIZARTINIB Cause Off label use? 47 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Off label use have been filed in association with QUIZARTINIB (VANFLYTA). This represents 13.2% of all adverse event reports for QUIZARTINIB.
47
Reports of Off label use with QUIZARTINIB
13.2%
of all QUIZARTINIB reports
2
Deaths
3
Hospitalizations
How Dangerous Is Off label use From QUIZARTINIB?
Of the 47 reports, 2 (4.3%) resulted in death, 3 (6.4%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for QUIZARTINIB. However, 47 reports have been filed with the FAERS database.
What Other Side Effects Does QUIZARTINIB Cause?
No adverse event (40)
Death (32)
Platelet count decreased (27)
Nausea (25)
Disease progression (20)
Pyrexia (20)
Electrocardiogram qt prolonged (19)
Febrile neutropenia (19)
Product dose omission issue (18)
Infection (17)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which QUIZARTINIB Alternatives Have Lower Off label use Risk?
QUIZARTINIB vs RABEPRAZOLE
QUIZARTINIB vs RACECADOTRIL
QUIZARTINIB vs RADIATION THERAPY
QUIZARTINIB vs RADIUM RA-223 DICHLORIDE
QUIZARTINIB vs RALOXIFENE